Indivior Pharmaceuticals, Inc. (INDV) Gross margin 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) gross margin by fiscal year — reported gross profit divided by reported revenue.
80.2%FY2025 · since FY2022: 83.1% → 80.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 80.2% | -0.3 pp |
| FY2024 | 80.6% | -3.5 pp |
| FY2023 | 84.1% | +1.0 pp |
| FY2022 | 83.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More INDV financial trends
INDV RevenueINDV Net incomeINDV Net marginINDV Gross profitINDV Operating incomeINDV Operating marginINDV Operating cash flowINDV Free cash flowINDV Capital expendituresINDV Return on equityINDV Stock buybacksINDV Dividends paidINDV Total assetsINDV Total liabilitiesINDV Shareholders’ equityINDV overview →